Comments
Drug firm Lupin on Thursday said it has received approval from the US health regulator to market a generic version of Tadalafil tablets, used to treat pulmonary arterial hypertension.
The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Eli Lilly and Company’s Adcirca tablets in 20 mg strength, Lupin said in a statement.
It is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability.
As per IQVIA MAT December 2018 data, Lupin said, the Tadalafil tablets, 20 mg had annual sales of around USD 474.3 million in the US.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.